Search results
Why AstraZeneca Stock Shot Higher Today
Motley Fool· 2 years agoWhat happened A convincing earnings beat on a very bullish day for the stock market was the powerful tailwind behind AstraZeneca's (NASDAQ: AZN) nearly...
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 months agoAstrazeneca (AZN) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 1 month agoAstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after...
Top Stock Reports for AstraZeneca, Caterpillar & Crown Castle
Zacks via Yahoo Finance· 2 years agoToday's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC...
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
Zacks via Yahoo Finance· 12 months agoAstrazeneca (AZN) closed at $73.85 in the latest trading session, marking a -0.28% move from the...
AstraZeneca PLC (LON:AZN) Shares Could Be 36% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 9 months agoKey Insights The projected fair value for AstraZeneca is UK£165 based on 2 Stage Free Cash Flow to...
Astrazeneca (AZN) Laps the Stock Market: Here's Why
Zacks via Yahoo Finance· 5 months agoIn the latest market close, Astrazeneca (AZN) reached $69.42, with a +0.35% movement compared to the previous day. This move outpaced the S&P 500's daily...
Astrazeneca (AZN) Stock Moves -0.83%: What You Should Know
Zacks via Yahoo Finance· 4 months agoAstrazeneca (AZN) closed at $66.64 in the latest trading session, marking a -0.83% move from the...
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
Investor's Business Daily· 1 year agoAstraZeneca on Monday said it has agreed to buy CinCor Pharma, maker of clinical-stage blood...
AstraZeneca (AZN) Beats on Q2 Earnings, Ups Sales Growth View
Zacks via Yahoo Finance· 2 years agoAstraZeneca's (AZN) second-quarter results reflect a beat on both counts (revenues and earnings)....